Publication: 2095

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
      QxMD      Google Scholar   
Citation:
J Thorac Oncol vol 10 (1) 143-147
Year:
2015
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
4
Parents:
762  
Children:
None
Program:
OGC
Primary Committee:
Respiratory
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA047577, U10 CA032291, CA33601, U10 CA077658, U10 CA029511, CA47577, CA29165, U10 CA045564, CA41287, U10 CA045808, CA03927, U10 CA031946, U10 CA033601, CA59518, U10 CA180821, CA45808, U10 CA059518, U10 CA035421, CA12046, U10 CA045418, CA35421, CA 37422, CA 21661, U10 CA041287, CA45564, U10 CA047559, U10 CA037422, U10 CA180882, CA21060, U10 CA021661, CA47559, CA45418, U10 CA180833, CA77658, U10 CA180867, CA31946, U10 CA003927  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
CALGB-30605
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Article